Anna Young, MD
Physical Medicine & Rehabilitation · Las Cruces, NMNPI 1083854947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations.
Across 53 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$288
- Smith+Nephew$150
- Kerecis Limited$118
- Paratek Pharmaceuticals, Inc.$118
- Terumo Medical Corporation$117
- Organogenesis Inc.$111
- plus $318 from 8 others
What the payments were for
- Food & beverage$1,220100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $288 |
| Smith+Nephew | 9 | $150 |
| Kerecis Limited | 1 | $118 |
| Paratek Pharmaceuticals, Inc. | 7 | $118 |
| Terumo Medical Corporation | 1 | $117 |
| Organogenesis Inc. | 7 | $111 |
| KCI USA, Inc. | 6 | $98 |
| Tactile Systems Technology Inc | 5 | $67 |
| Solventum Corporation | 3 | $57 |
| Hydrofera LLC | 1 | $25 |
| Convatec Inc. | 1 | $22 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Merck | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$473
- EMBLAVEO$125
- Kerecis GraftGuide$118
- AngioSeal$117
- TR Band$117
- AZUR$117
- Navicross$117
How this compares
$1,220 in reported general payments places this provider in the 75th percentile of 41 physical medicine & rehabilitation providers in New Mexico.
See all physical medicine & rehabilitation providers in New Mexico →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 12 | $294 |
| Doxycycline Hyclate | 20 | $292 |
| Mupirocin | 16 | $173 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Las Cruces
- Kimberly EncaperaLas Cruces$126
- Jonathan EllenLas Cruces$126
- Robert BiedermannLas Cruces$14
- Reza EhsanianAlbuquerque$19K
- Christopher BurtonAlbuquerque$10K
- Martin ManansalaAlbuquerque$7K
- Terry HansenAlbuquerque$7K
- John SloanAlbuquerque$6K
- Jack ChienAlbuquerque$5K
- Julie MucheAlbuquerque$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.